Insulin-containing polymer composition for oral administration

Details Insulin-containing polymer composition for oral administration Insulin-containing polymer composition for oral administration

1995-03-22

1997-12-16

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

424487, 514 4, A61K 3828, A61K 4730

Patent

active

056985150

ABSTRACT:
An insulin-containing polymer composition intended for the oral administration of insulin, which comprises a hydrophilic polymer modified with an inhibitor of proteolytic enzyme, insulin and water, wherein the inhibitor of proteolytic enzymes is ovomucoid isolated from duck or turkey egg whites.

REFERENCES:
patent: 4238480 (1980-12-01), Sawyer
patent: 4579730 (1986-04-01), Kidron et al.
patent: 4795436 (1989-01-01), Robinson
patent: 4849227 (1989-07-01), Cho
patent: 5049545 (1991-09-01), Lobermann et al.
patent: 5206219 (1993-04-01), Desai
patent: 5340731 (1994-08-01), Kilburn et al.
patent: 5438040 (1995-08-01), Ekwuribe
patent: 5563056 (1996-10-01), Swan et al.
"Thermally Reversible Hydrogels Containing Biologically Active Species", Hoffman, Polymers in Medicine III, Elsevier Science Publishers B.V., Amsterdam, 1988, pp. 161-167.
"The Acetylation of Insulin", Lindsay et al, Biochem. J. 121 (1971), p. 737.
"Monosubstituted 2,2-Dimethyl-3-Formyl-L-Thiazolidine-4-Carbonyl Insulins", Lindsay et al, Eur. J. Biochem. 15 (1970) p. 547.
"Intramolecular Cross-Linked Insulin", D.G. Lindsay, Mar. 1971, Febs Lett., vol. 21, No. 1, p. 105.
"Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats", Hashizume et al, J. Pharm. Pharmacol. 1992, 44:557-558.
"Trials of Lipid Modification of Peptide Hormones for Intestinal Delivery", Muranishi et al, Journal of Controlled Release, 19 (1992), PP. 179-180.
"Hypoglycemic Effect of Intestinally Administered Monosaccharide-Modified Insulin Derivatives in Rats", Haga et al, Chem. Pharm. Bull. 39(7) (1990), pp. 1983 & 1986.
"Effect of Trypsin Inhibitor on Passage of Insulin Across the Intestinal Barrier", Science, 127, 1988, pp. 1115-1116.
Seals, J.R. Evidence That Insulin Activates an Intrinsic Plasma Membrane. J. Biol. Chem. Jul. 25, 1980. vol. 255, No. 14, pp. 6529-6531.
Braganza, V.J. et al. Tryptase from Rat Skin. Biochemistry. 1991. vol. 30, No. 20, pp. 4997-5007.
Morishita, I. et al. Hypoglycemic Effect of Novel Oral Microspheres of Insulin. Int. J. Pharm. 1992 pp. 9-16.
Greenley, R.Z., et al. "Polymer Matrices for Oral Delivery". Polymer Preprints, vol. 31, No. 2 (Aug. 1990, Papers Presented at the Washington, D.C. Meeting, American Chemical Society, pp. 182-183.
Saffran, Murray, et al., "Biodegradable Azopolymer Coating . . . " Biochemical Society Transactions, vol. 18 (1990), pp. 752-754.
Damge, C., et al., "Nanocapsules as Carriers for Oral Peptide Delivery". Journal of Controlled Release, vol. 13 (1990), pp. 233-239.

Affiliated with

Also associated with

Rating

Insulin-containing polymer composition for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-containing polymer composition for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-containing polymer composition for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-205946